Country: United States
Language: English
Source: NLM (National Library of Medicine)
POLY(N-ACETYL, N-ARGINYL)GLUCOSAMINE (50000-80000 MW) (UNII: UA7MY2JY0E) (POLY(N-ACETYL, N-ARGINYL)GLUCOSAMINE (50000-80000 MW) - UNII:UA7MY2JY0E)
Synedgen, Inc.
POLYGLUCOSAMINE GLUCOSAMINE - UNII:UA7MY2JY0E)
POLY(N-ACETYL, N-ARGINYL)GLUCOSAMINE (50000-80000 MW) 1 g in 1 g
TOPICAL
PRESCRIPTION
Derived from chitin obtained from Arctic shrimp shells, Synoplex® has an approximate molecular weight of 20 to 100 kDa. Each gram of Synoplex® contains 1 gram of poly (acetyl, arginyl) glucosamine. Synoplex® is supplied as a dry soluble powder, that is rehydrated with sterile water prior to use. Synoplex® acts on the bacterial membrane causing aggregation of bacteria and pore formation leading to reduction of viable bacteria and prevention of biofilm formation.
Synoplex® is supplied as a dry soluble powder in amber glass bottles containing 1-gram of poly (acetyl, arginyl) glucosamine. Synoplex® is packaged in cartons containing either one (1) bottle or five (5) bottles of 1-gram of poly (acetyl, arginyl) glucosamine.
Legally Marketed Unapproved New Animal Drugs for Minor Species
SYNOPLEX- POLY (ACETYL, ARGINYL) GLUCOSAMINE POWDER, FOR SOLUTION SYNEDGEN, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- SYNOPLEX® (POLY(ACETYL, ARGINYL) GLUCOSAMINE) WOUND RINSE, 1G CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. For topical use on animals in the family Elephantidae and Rhinocerotidae only. Not intended for oral, parenteral, or ocular administration. NOT APPROVED BY FDA - Legally marketed as an FDA Indexed Product under MIF 900-012. Extra- label use is prohibited. Note---In order to be legally marketed, an animal drug product intended for a minor species must be Approved, Conditionally Approved, or Indexed by the FDA. THIS PRODUCT IS INDEXED. It is a violation of Federal law to use this product in a manner other than as directed in the labeling. NET CONTENTS: 1 g poly(acetyl, arginyl) glucosamine/amber glass bottle DESCRIPTION Derived from chitin obtained from Arctic shrimp shells, Synoplex® has an approximate molecular weight of 20 to 100 kDa. Each gram of Synoplex® contains 1 gram of poly (acetyl, arginyl) glucosamine. Synoplex® is supplied as a dry soluble powder, that is rehydrated with sterile water prior to use. Synoplex® acts on the bacterial membrane causing aggregation of bacteria and pore formation leading to reduction of viable bacteria and prevention of biofilm formation. Synoplex Bottle Label INDICATION For topical application on animals in the family Elephantidae and Rhinocerotidae for treatment of foot and dermal lesions infected with aerobic or facultative anaerobic Gram-positive and/or Gram-negative bacteria; and for treatment of sterile chronic foot and dermal lesions. FOR USE IN ANIMALS IN THE FAMILY ELEPHANTIDAE AND RHINOCEROTIDAE ONLY; THIS PRODUCT IS NOT TO BE USED IN ANIMALS INTENDED FOR USE AS FOOD FOR HUMANS OR OTHER ANIMALS. WARNING NOT FOR USE IN HUMANS. KEEP OUT O Read the complete document